BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 16135487)

  • 1. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.
    Peeters KC; van de Velde CJ; Leer JW; Martijn H; Junggeburt JM; Kranenbarg EK; Steup WH; Wiggers T; Rutten HJ; Marijnen CA
    J Clin Oncol; 2005 Sep; 23(25):6199-206. PubMed ID: 16135487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late adverse effects of short-course preoperative radiotherapy in rectal cancer.
    Pollack J; Holm T; Cedermark B; Altman D; Holmström B; Glimelius B; Mellgren A
    Br J Surg; 2006 Dec; 93(12):1519-25. PubMed ID: 17054311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence the adequacy of total mesorectal excision for rectal cancer.
    Jeyarajah S; Sutton CD; Miller AS; Hemingway D;
    Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of short-course radiotherapy and low anterior resection on quality of life and bowel function in primary rectal cancer.
    Murata A; Brown CJ; Raval M; Phang PT
    Am J Surg; 2008 May; 195(5):611-5; discussion 615. PubMed ID: 18367144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of preoperative radiotherapy in patients with rectal cancer undergoing total mesorectal excision: a study of the Dutch Colorectal Cancer Group.
    Van Den Brink M; Van Den Hout WB; Stiggelbout AM; Klein Kranenbarg E; Marijnen CA; Van De Velde CJ; Kievit J;
    J Clin Oncol; 2004 Jan; 22(2):244-53. PubMed ID: 14665610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
    Krempien R; Roeder F; Oertel S; Roebel M; Weitz J; Hensley FW; Timke C; Funk A; Bischof M; Zabel-Du Bois A; Niethammer AG; Eble MJ; Buchler MW; Treiber M; Debus J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1143-51. PubMed ID: 16979835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Pudełko M; Kryj M; Oledzki J; Szmeja J; Słuszniak J; Serkies K; Kładny J; Pamucka M; Kukołowicz P
    Radiother Oncol; 2004 Jul; 72(1):15-24. PubMed ID: 15236870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group.
    Kapiteijn E; Kranenbarg EK; Steup WH; Taat CW; Rutten HJ; Wiggers T; van Krieken JH; Hermans J; Leer JW; van de Velde CJ
    Eur J Surg; 1999 May; 165(5):410-20. PubMed ID: 10391155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative complications of curative treatment for rectal cancer in males with sphincter-preserving total mesorectal excision].
    Szynglarewicz B; Matkowski R; Sydor D; Forgacz J; Pudełko M; Grzebieniak Z
    Pol Merkur Lekarski; 2007 Nov; 23(137):348-51. PubMed ID: 18361317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands.
    Kapiteijn E; Putter H; van de Velde CJ;
    Br J Surg; 2002 Sep; 89(9):1142-9. PubMed ID: 12190680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
    Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
    Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for faecal incontinence after rectal cancer treatment.
    Lange MM; den Dulk M; Bossema ER; Maas CP; Peeters KC; Rutten HJ; Klein Kranenbarg E; Marijnen CA; van de Velde CJ;
    Br J Surg; 2007 Oct; 94(10):1278-84. PubMed ID: 17579345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.
    Marijnen CA; van de Velde CJ; Putter H; van den Brink M; Maas CP; Martijn H; Rutten HJ; Wiggers T; Kranenbarg EK; Leer JW; Stiggelbout AM
    J Clin Oncol; 2005 Mar; 23(9):1847-58. PubMed ID: 15774778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of a validated instrument to evaluate bowel function after sphincter-preserving surgery for rectal cancer.
    Temple LK; Bacik J; Savatta SG; Gottesman L; Paty PB; Weiser MR; Guillem JG; Minsky BD; Kalman M; Thaler HT; Schrag D; Wong WD
    Dis Colon Rectum; 2005 Jul; 48(7):1353-65. PubMed ID: 15868235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of total mesorectal excision and preoperative chemoradiotherapy on local recurrence in rectal cancer].
    Wu AW; Gu J; Wang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):207-9. PubMed ID: 16721678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery.
    Lange MM; Maas CP; Marijnen CA; Wiggers T; Rutten HJ; Kranenbarg EK; van de Velde CJ;
    Br J Surg; 2008 Aug; 95(8):1020-8. PubMed ID: 18563786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.
    Folkesson J; Birgisson H; Pahlman L; Cedermark B; Glimelius B; Gunnarsson U
    J Clin Oncol; 2005 Aug; 23(24):5644-50. PubMed ID: 16110023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative radiotherapy improves outcome in recurrent rectal cancer.
    Vermaas M; Ferenschild FT; Nuyttens JJ; Marinelli AW; Wiggers T; van der Sijp JR; Verhoef C; Graveland WJ; Eggermont AM; de Wilt JH
    Dis Colon Rectum; 2005 May; 48(5):918-28. PubMed ID: 15785886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.